Arizona Clinical Trials

Recruiting studies in Arizona

• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583Limited-stage Small Cell Lung Cancer (LS-SCLC)Goodyear, AZ
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060Episodic MigraineChandler, AZ
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723Chronic Kidney Disease and HypertensionSurprise, AZ
• A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
  NCT04657068Advanced CancerScottsdale, AZ
• GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
  NCT03821129StrokeTucson, AZ
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
  NCT06667076Carcinoma, Non-Small-Cell LungGoodyear, AZ
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
  NCT06598943Ulcerative ColitisChandler, AZ
• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
  NCT06172296Ganglioneuroblastoma, NodularMesa, AZ
• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  NCT06623422Carcinoma, Non-Small-Cell LungGilbert, AZ
• Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
  NCT06337318Classic Follicular LymphomaPhoenix, AZ
• A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
  NCT04166409Low Grade AstrocytomaMesa, AZ
• Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
  NCT04181060Advanced Lung Non-Squamous Non-Small Cell CarcinomaPhoenix, AZ

See all 1,686 recruiting Arizona trials →

Clinical trials by Arizona metro

• Phoenix

Popular conditions in Arizona

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Arizona?

Corterve aggregates actively recruiting clinical trials with sites in Arizona from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.

Are clinical trials in Arizona free to join?

Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.

What kinds of clinical trials are available in Arizona?

Arizona research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.